• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

创伤性脑损伤与载脂蛋白E4在阿尔茨海默病患者中的协同作用。

Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease.

作者信息

Mayeux R, Ottman R, Maestre G, Ngai C, Tang M X, Ginsberg H, Chun M, Tycko B, Shelanski M

机构信息

Gertrude H. Sergievsky Center, Columbia University, New York, NY 10032.

出版信息

Neurology. 1995 Mar;45(3 Pt 1):555-7. doi: 10.1212/wnl.45.3.555.

DOI:10.1212/wnl.45.3.555
PMID:7898715
Abstract

The apolipoprotein-epsilon 4 allele increases the risk of Alzheimer's disease (AD), but cerebral deposition of beta-amyloid with age, a genetic mutation, or head injury may contribute to the pathogenesis of this disease. We examined the risks of AD associated with traumatic head injury and apolipoprotein-epsilon 4 in 236 community-dwelling elderly persons. A 10-fold increase in the risk of AD was associated with both apolipoprotein-epsilon 4 and a history of traumatic head injury, compared with a two-fold increase in risk with apolipoprotein-epsilon 4 alone. Head injury in the absence of an apolipoprotein-epsilon 4 allele did not increase risk. These data imply that the biological effects of head injury may increase the risk of AD, but only through a synergistic relationship with apolipoprotein-epsilon 4.

摘要

载脂蛋白ε4等位基因会增加患阿尔茨海默病(AD)的风险,但随着年龄增长、基因突变或头部受伤导致的β-淀粉样蛋白在大脑中的沉积可能会促使该病的发病。我们对236名居住在社区的老年人进行了研究,以检测与创伤性脑损伤及载脂蛋白ε4相关的AD风险。与仅携带载脂蛋白ε4时风险增加两倍相比,载脂蛋白ε4和有创伤性脑损伤病史都会使AD风险增加10倍。不存在载脂蛋白ε4等位基因时的头部损伤不会增加风险。这些数据表明,头部损伤的生物学效应可能会增加AD风险,但仅通过与载脂蛋白ε4的协同关系来实现。

相似文献

1
Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease.创伤性脑损伤与载脂蛋白E4在阿尔茨海默病患者中的协同作用。
Neurology. 1995 Mar;45(3 Pt 1):555-7. doi: 10.1212/wnl.45.3.555.
2
Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease.年龄、种族和头部损伤对载脂蛋白E(APOE)基因分型与阿尔茨海默病之间关联的影响。
Ann N Y Acad Sci. 1996 Dec 16;802:6-15. doi: 10.1111/j.1749-6632.1996.tb32593.x.
3
Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury.载脂蛋白E ε4等位基因与头部受伤后β-淀粉样蛋白的沉积有关。
Nat Med. 1995 Feb;1(2):135-7. doi: 10.1038/nm0295-135.
4
Amyloid beta-protein, APOE genotype and head injury.淀粉样β蛋白、载脂蛋白E基因型与头部损伤。
Ann N Y Acad Sci. 1996 Jan 17;777:271-5. doi: 10.1111/j.1749-6632.1996.tb34431.x.
5
Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.载脂蛋白E、痴呆与β-淀粉样蛋白的皮质沉积
N Engl J Med. 1995 Nov 9;333(19):1242-7. doi: 10.1056/NEJM199511093331902.
6
Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease.载脂蛋白E基因分型对阿尔茨海默病中淀粉样蛋白沉积和神经原纤维缠结形成的影响。
Neuroscience. 1995 Dec;69(3):757-61. doi: 10.1016/0306-4522(95)00331-c.
7
Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease.载脂蛋白E、阿尔茨海默病患者的生存情况以及死亡和阿尔茨海默病的竞争风险
Neurology. 1995 Jul;45(7):1323-8. doi: 10.1212/wnl.45.7.1323.
8
Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians.尼日利亚老年人中载脂蛋白E ε4与阿尔茨海默病之间不存在关联。
Ann Neurol. 1995 Sep;38(3):463-5. doi: 10.1002/ana.410380319.
9
Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.载脂蛋白E基因分型与头部损伤及阿尔茨海默病风险
Am J Epidemiol. 1997 Sep 1;146(5):373-84. doi: 10.1093/oxfordjournals.aje.a009290.
10
Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease.载脂蛋白E-ε4等位基因与阿尔茨海默病的家族风险
Genet Epidemiol. 1996;13(3):285-98. doi: 10.1002/(SICI)1098-2272(1996)13:3<285::AID-GEPI5>3.0.CO;2-5.

引用本文的文献

1
Recent Advances in Drug Development for Alzheimer's Disease: A Comprehensive Review.阿尔茨海默病药物研发的最新进展:全面综述
Int J Mol Sci. 2025 Apr 21;26(8):3905. doi: 10.3390/ijms26083905.
2
Traumatic Brain Injury and Chronic Traumatic Encephalopathy: Not Only Trigger for Neurodegeneration but Also for Cerebral Amyloid Angiopathy?创伤性脑损伤与慢性创伤性脑病:不仅是神经退行性变的触发因素,也是脑淀粉样血管病的触发因素?
Biomedicines. 2025 Apr 5;13(4):881. doi: 10.3390/biomedicines13040881.
3
Traumatic brain injury: molecular biomarkers, genetics, secondary consequences, and medical management.
创伤性脑损伤:分子生物标志物、遗传学、继发性后果及医学管理
Front Neurosci. 2024 Oct 4;18:1446076. doi: 10.3389/fnins.2024.1446076. eCollection 2024.
4
Biofluid-based Biomarkers in Traumatic Brain Injury: A Narrative Review.创伤性脑损伤中基于生物流体的生物标志物:一篇叙述性综述。
Brain Neurorehabil. 2024 Mar 18;17(1):e8. doi: 10.12786/bn.2024.17.e8. eCollection 2024 Mar.
5
ApoE Isoforms Inhibit Amyloid Aggregation of Proinflammatory Protein S100A9.载脂蛋白 E 异构体抑制促炎蛋白 S100A9 的淀粉样纤维聚集。
Int J Mol Sci. 2024 Feb 9;25(4):2114. doi: 10.3390/ijms25042114.
6
Periodontitis and brain magnetic resonance imaging markers of Alzheimer's disease and cognitive aging.牙周炎与阿尔茨海默病和认知老化的脑磁共振成像标志物。
Alzheimers Dement. 2024 Mar;20(3):2191-2208. doi: 10.1002/alz.13683. Epub 2024 Jan 26.
7
Biomimetic Surface Engineering to Modulate the Coffee-Ring Effect for Amyloid-β Detection in Rat Brains.用于调节咖啡环效应以检测大鼠脑中β-淀粉样蛋白的仿生表面工程
Biomimetics (Basel). 2023 Dec 1;8(8):581. doi: 10.3390/biomimetics8080581.
8
Age, sex, and apolipoprotein E isoform alter contextual fear learning, neuronal activation, and baseline DNA damage in the hippocampus.年龄、性别和载脂蛋白 E 异构体改变了海马体的情景性恐惧学习、神经元激活和基线 DNA 损伤。
Mol Psychiatry. 2023 Aug;28(8):3343-3354. doi: 10.1038/s41380-023-01966-8. Epub 2023 Feb 2.
9
How Traumatic Brain Injury History Relates to Brain Health MRI Markers and Dementia Risk: Findings from the 3C Dijon Cohort.创伤性脑损伤史与脑健康 MRI 标志物和痴呆风险的关系:来自第戎 3C 队列的研究结果。
J Alzheimers Dis. 2023;92(1):183-193. doi: 10.3233/JAD-220658.
10
Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer's dementia.载脂蛋白 E4 携带者和阿尔茨海默病患者死后脑组织中类二十烷酸脂质组的激活。
Alzheimers Res Ther. 2022 Oct 11;14(1):152. doi: 10.1186/s13195-022-01084-7.